Vivos Therapeutics, Inc. (VVOS)
NASDAQ: VVOS · Real-Time Price · USD
1.330
-0.050 (-3.62%)
At close: Mar 6, 2026, 4:00 PM EST
1.340
+0.010 (0.75%)
After-hours: Mar 6, 2026, 5:59 PM EST
Vivos Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2018 |
| Revenue | 17.32 | 15.03 | 13.8 | 16.02 | 16.89 | 13.07 | Upgrade
|
| Revenue Growth (YoY) | 18.76% | 8.91% | -13.87% | -5.10% | 29.23% | 14.68% | Upgrade
|
| Cost of Revenue | 7.67 | 6.01 | 5.53 | 6.01 | 4.28 | 2.65 | Upgrade
|
| Gross Profit | 9.65 | 9.02 | 8.27 | 10.02 | 12.6 | 10.41 | Upgrade
|
| Selling, General & Admin | 24.96 | 19.61 | 24.95 | 34.18 | 31.34 | 18.4 | Upgrade
|
| Research & Development | - | - | - | 0.2 | - | - | Upgrade
|
| Operating Expenses | 25.97 | 20.19 | 25.57 | 35.05 | 32.08 | 19.12 | Upgrade
|
| Operating Income | -16.32 | -11.17 | -17.3 | -25.03 | -19.47 | -8.71 | Upgrade
|
| Interest Expense | - | - | - | - | -0.01 | -0.1 | Upgrade
|
| Interest & Investment Income | - | - | - | - | - | 0.08 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.79 | 0.04 | 3.71 | -0.1 | 0.11 | - | Upgrade
|
| EBT Excluding Unusual Items | -17.1 | -11.14 | -13.58 | -25.13 | -19.38 | -8.73 | Upgrade
|
| Asset Writedown | - | - | - | - | -0.91 | - | Upgrade
|
| Other Unusual Items | - | - | - | 1.29 | - | -3.33 | Upgrade
|
| Pretax Income | -17.1 | -11.14 | -13.58 | -23.85 | -20.29 | -12.06 | Upgrade
|
| Net Income | -17.1 | -11.14 | -13.58 | -23.85 | -20.29 | -12.06 | Upgrade
|
| Preferred Dividends & Other Adjustments | - | - | - | - | - | 5.93 | Upgrade
|
| Net Income to Common | -17.1 | -11.14 | -13.58 | -23.85 | -20.29 | -17.99 | Upgrade
|
| Shares Outstanding (Basic) | 9 | 5 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 9 | 5 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 151.68% | 311.68% | 32.46% | 8.39% | 65.00% | 4.36% | Upgrade
|
| EPS (Basic) | -1.91 | -2.22 | -11.14 | -25.90 | -23.89 | -34.94 | Upgrade
|
| EPS (Diluted) | -1.91 | -2.22 | -11.14 | -25.90 | -23.89 | -34.94 | Upgrade
|
| Free Cash Flow | -15.37 | -13.26 | -12.8 | -20.51 | -18.13 | -5.8 | Upgrade
|
| Free Cash Flow Per Share | -1.71 | -2.64 | -10.50 | -22.28 | -21.35 | -11.27 | Upgrade
|
| Gross Margin | 55.73% | 60.00% | 59.93% | 62.52% | 74.65% | 79.70% | Upgrade
|
| Operating Margin | -94.23% | -74.32% | -125.32% | -156.21% | -115.31% | -66.65% | Upgrade
|
| Profit Margin | -98.76% | -74.09% | -98.42% | -148.81% | -120.15% | -137.67% | Upgrade
|
| Free Cash Flow Margin | -88.73% | -88.21% | -92.74% | -128.00% | -107.38% | -44.39% | Upgrade
|
| EBITDA | -15.31 | -10.59 | -16.68 | -24.36 | -18.74 | -7.99 | Upgrade
|
| EBITDA Margin | -88.39% | -70.45% | -120.82% | -152.03% | -110.97% | -61.16% | Upgrade
|
| D&A For EBITDA | 1.01 | 0.58 | 0.62 | 0.67 | 0.73 | 0.72 | Upgrade
|
| EBIT | -16.32 | -11.17 | -17.3 | -25.03 | -19.47 | -8.71 | Upgrade
|
| EBIT Margin | -94.23% | -74.32% | -125.32% | -156.21% | -115.31% | -66.65% | Upgrade
|
| Revenue as Reported | 17.32 | 15.03 | 13.8 | 16.02 | 16.89 | 13.07 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.